RxDoctor Payments Data

Amber Bullard, APRN

Family · Columbia, SCNPI 1023694163

Payments from drug & device makers

$942in general payments, 2019–2025

Across 56 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$214
  • Pfizer$185
  • AstraZeneca$168
  • Lundbeck LLC$60
  • Astellas Pharma US Inc$44
  • Philips North America LLC$29
  • plus $241 from 13 others

What the payments were for

  • Food & beverage$942100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$942 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$1,597
Medicare patients
13
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$16,863
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$7,662
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,035
Albuterol Sulfate HfaAlbuterol Sulfate28$724
Acetaminophen-CodeineAcetaminophen With Codeine18$530
Nebivolol Hcl13$470
Duloxetine Hcl27$441
Atorvastatin Calcium54$357
Levothyroxine Sodium44$266
Gabapentin21$253
Escitalopram Oxalate22$227
Diazepam30$226
Losartan Potassium25$218
Oxybutynin Chloride11$203
Metoprolol Succinate12$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKAnoro Ellipta$17$7,66212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,248 family providers in South Carolina.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →